Publications | Lund University Publications

31 – 40 of 41

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=issn+exact+%220923-7534%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2012
Mark Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases : A randomized eortc intergroup phase ii study (EORTC 40004)
Ruers, T. ; Punt, C. ; Van coevorden, F. ; Pierie, J. P.E.N. ; Borel-Rinkes, I. ; Ledermann, J. A. ; Poston, G. ; Bechstein, W. ; Lentz, M. A. and Mauer, M. , et al. (2012) In Annals of Oncology 23(10). p.2619-2626
- Contribution to journal › Article
2009
Mark Tyrosine kinase inhibition in renal cell carcinoma and gastrointestinal stromal tumours: case reports
Schoffski, P. ; Bukowski, R. ; Flodgren, Per ^LU and Ravaud, A. (2009) Symposium on Expanding the Boundaries of Clinical Practice - Building an Experience with Targeted Therapies 20. p.25-31
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
2007
Mark Familial blood vessel tumors and subsequent cancers
Ji, J. ^LU and Hemminki, K. ^LU (2007) In Annals of Oncology 18(7). p.1260-1267
- Contribution to journal › Article
2005
Mark 2004 consensus statements on the management of ovarian cancer : final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)
du Bois, A ; Quinn, M ; Thigpen, T ; Vermorken, J ; Avall-Lundqvist, E ; Bookman, M ; Bowtell, D ; Brady, M ; Casado, A and Cervantes, A , et al. (2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16 Suppl 8. p.7-12
- Contribution to journal › Article
Mark Clinical trials in ovarian carcinoma : study methodology
Vermorken, J B ; Parmar, M K B ; Brady, M F ; Eisenhauer, E A ; Hogberg, T ^LU ; Ozols, R F ; Rochon, J ; Rustin, G J S ; Sagae, S and Verheijen, R H M (2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16(Suppl 8). p.20-29
- Contribution to journal › Article
Mark 3rd International Ovarian Cancer Consensus Conference : outstanding issues for future consideration
Stuart, G ; Avall-Lundqvist, E ; du Bois, A ; Bookman, M ; Bowtell, D ; Brady, M ; Casado, A ; Cervantes, A ; Eisenhauer, E and Friedlaender, M , et al. (2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16(Suppl 8). p.36-38
- Contribution to journal › Article
2000
Mark Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
Tropé, C ; Kaern, J ; Hogberg, T ^LU ; Abeler, V ; Hagen, B ; Kristensen, G ; Onsrud, M ; Pettersen, E ; Rosenberg, P and Sandvei, R , et al. (2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(3). p.8-281
- Contribution to journal › Article
Mark ErbB2 status and the benefit from two or five years of adjuvant tamoxifen in postmenopausal early stage breast cancer
Stål, O ; Borg, A ; Fernö, M ^LU ; Källström, A C ; Malmström, P ^LU and Nordenskjöld, B (2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(12). p.1545-1550
- Contribution to journal › Article
1998
Mark Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer : the Nordic experience
Tropé, C ; Hogberg, T ^LU ; Kaern, J ; Bertelsen, K ; Bjorkholm, E ; Boman, K ; Himmelmann, A ; Horvath, G ; Jacobsen, A and Kuoppola, T , et al. (1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(12). p.1301-1307
- Contribution to journal › Article
Mark Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients. Scandinavian Breast Group, Study SBG 9401
Bergh, J ; Wiklund, T ; Erikstein, B ; Fornander, T ; Bengtsson, N O ; Malmström, P ^LU ; Kellokumpu-Lehtinen, P ; Anker, G ; Bennmarker, H and Wilking, N ^LU (1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(4). p.403-411
- Contribution to journal › Article

your query:: Remove issn: 0923-7534